Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
QJM : Monthly Journal of the Association of Physicians
|
September 20, 2005
COX and cancer
D Mazhar, R Gillmore, J Waxman
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 5, 2011
Clinical examination does not assist in the detection of systemic relapse of testicular germ cell tumour
N G Cunniffe, J Robson, D Mazhar, et al.
Journal of Gastroenterology and Hepatology
|
May 14, 2011
Education and imaging. Hepatobiliary and pancreatic: peliosis hepatis
A J Fowell, D Mazhar, A S Shaw, et al.
Oncology
|
June 3, 2008
Late relapse of stage i seminoma following single-agent carboplatin
S Raj, M V Williams, A K Dixon, et al.
Journal Francais D'Ophtalmologie
|
November 10, 2021
[Atypical inflammmatory presentation of an iris juvenile xanthogranuloma in a 10-month-old girl]
D Mazhar, J-B Ducloyer, P Lebranchu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2005
The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma
J Stebbing, D Mazhar, R Lewis, et al.
Oncology Reports
|
December 5, 2006
Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer
W Heller, D Mazhar, R Ward, et al.
British Journal of Cancer
|
August 18, 2011
Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
Y Rimmer, J Chester, J Joffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)
J Shamash, S-J Sarker, R Huddart, et al.
Gene Therapy
|
January 14, 2005
Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-alpha and the transcriptional repressor PLZF
L Buluwela, J Pike, D Mazhar, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
QJM : Monthly Journal of the Association of Physicians
|
September 20, 2005
COX and cancer
D Mazhar, R Gillmore, J Waxman
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 5, 2011
Clinical examination does not assist in the detection of systemic relapse of testicular germ cell tumour
N G Cunniffe, J Robson, D Mazhar, et al.
Journal of Gastroenterology and Hepatology
|
May 14, 2011
Education and imaging. Hepatobiliary and pancreatic: peliosis hepatis
A J Fowell, D Mazhar, A S Shaw, et al.
Oncology
|
June 3, 2008
Late relapse of stage i seminoma following single-agent carboplatin
S Raj, M V Williams, A K Dixon, et al.
Journal Francais D'Ophtalmologie
|
November 10, 2021
[Atypical inflammmatory presentation of an iris juvenile xanthogranuloma in a 10-month-old girl]
D Mazhar, J-B Ducloyer, P Lebranchu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2005
The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma
J Stebbing, D Mazhar, R Lewis, et al.
Oncology Reports
|
December 5, 2006
Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer
W Heller, D Mazhar, R Ward, et al.
British Journal of Cancer
|
August 18, 2011
Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
Y Rimmer, J Chester, J Joffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)
J Shamash, S-J Sarker, R Huddart, et al.
Gene Therapy
|
January 14, 2005
Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-alpha and the transcriptional repressor PLZF
L Buluwela, J Pike, D Mazhar, et al.
Page
of 3